Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

2010

Biotron HCV Drug: International Partner to Progress Trial

30 April 201318 March 2010 by Karen Mobbs

Biotron HCV Drug: International Partner to Progress Trial

Categories 2010

Half-year report 31 December 2009

30 April 201326 February 2010 by Karen Mobbs

Half-year report 31 December 2009

Categories 2010, Half-year reports

Allotment and Distribution of New Options

30 April 20135 February 2010 by Karen Mobbs

Allotment and Distribution of New Options

Categories 2010

Quarterly Report 31 December 2009

30 April 201327 January 2010 by Karen Mobbs

Quarterly Report 31 December 2009

Categories 2010, Quarterly Reports

Change of Director’s Interest Notice

30 April 201322 January 2010 by Karen Mobbs

Change of Director’s Interest Notice

Categories 2010

Entitlement Issue 23% Oversubscribed

30 April 201315 January 2010 by Karen Mobbs

Entitlement Issue 23% Oversubscribed

Categories 2010
Newer posts
← Previous Page1 Page2 Page3
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 11 February 2026        Legal Notices and Privacy
Cleantalk Pixel